Video
Scott Snapper, professor at Harvard Medical School, talks about IBD and therapeutic possibilities based on the manipulation of the intestinal microbiota.
In the pathogenesis of IBDs, the gut microbiota plays a key role. Treating gut dysbiosis may be a solutions, so companies are exploring this possibility.
We asked Laurence Zitvogel about the advances in the field of oncological immunotherapy and the role of microbiome.
Ted Dinan of University College Cork, Ireland, gives us an insight into the intestine-brain axis.
